BDBM756044 3-(5-(1-methyl-4-((8-methyl-3,8- diazabicyclo[3.2.1]octan-3- yl)methyl)-1H-pyrrolo[2,3- b]pyridin-6-yl)-1-oxoisoindolin-2- yl)piperidine-2,6-dione::US20250214991, Compound 311

SMILES CN1C2CCC1CN(Cc1cc(-c3ccc4c(c3)CN(C3CCC(=O)NC3=O)C4=O)nc3c1ccn3C)C2

InChI Key InChIKey=HXXVPZCRGAMYDT-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 756044   

TargetDNA damage-binding protein 1/Protein cereblon(Human)
Oncopia Therapeutics, Inc. D/B/A/ Sk Life Science Labs

US Patent
LigandChemical structure of BindingDB Monomer ID 756044BDBM756044(3-(5-(1-methyl-4-((8-methyl-3,8- diazabicyclo[3.2....)
Affinity DataIC50: 65nMAssay Description:The binding potency was determined using HTRF assay technology (Perkin Elmer). Compounds were serially diluted in DMSO and 0.2 μL volume was transfer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent